Tenaya Therapeutics SG&A Expense (Quarterly) Insights

Tenaya Therapeutics Inc (TNYA)

4.68 +0.06 (+1.30%) USD | NASDAQ | May 03, 16:00

4.68 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2020. Upgrade now.

Date	Value
December 31, 2023	8.581M
September 30, 2023	7.829M
June 30, 2023	8.627M
March 31, 2023	8.118M
December 31, 2022	8.802M
September 30, 2022	7.54M
June 30, 2022	7.743M
March 31, 2022	6.999M

Date	Value
December 31, 2021	5.211M
September 30, 2021	5.356M
June 30, 2021	4.331M
March 31, 2021	3.515M
December 31, 2020	1.958M
September 30, 2020	1.972M
June 30, 2020	1.914M
March 31, 2020	1.969M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

1.914M

Minimum

Jun 2020

8.802M

Maximum

Dec 2022

5.654M

Average

6.178M

Median

SG&A Expense (Quarterly) Benchmarks